Juliana G. Melgaco

Fiocruz, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Inherited IFNAR1 structural deficiency in severe adverse events following yellow fever vaccination.

Inherited IFNAR1 structural deficiency in severe adverse events following yellow fever vaccination.

Journal: Clinical immunology (Orlando, Fla.)

Published: March 19, 2026

Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233.

Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233.

Journal: Viruses

Published: September 15, 2025

CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study.

CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study.

Journal: Viruses

Published: August 27, 2025

Immunomodulatory effect of bovine lactoferrin during SARS-CoV-2 infection.

Immunomodulatory effect of bovine lactoferrin during SARS-CoV-2 infection.

Journal: Frontiers in immunology

Published: June 28, 2024

Congenital Zika virus infection in laboratory animals: a comparative review highlights translational studies on the maternal-foetal interface.

Congenital Zika virus infection in laboratory animals: a comparative review highlights translational studies on the maternal-foetal interface.

Journal: Memorias do Instituto Oswaldo Cruz

Published: June 17, 2024

Decidual production of interferon lambda in response to ZIKV persistence: Clinical evidence and in vitro modelling.

Decidual production of interferon lambda in response to ZIKV persistence: Clinical evidence and in vitro modelling.

Journal: Heliyon

Published: December 20, 2023

SARS-CoV-2 and dialysis: humoral response, clinical and laboratory impacts before vaccination.

SARS-CoV-2 and dialysis: humoral response, clinical and laboratory impacts before vaccination.

Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Published: October 06, 2023

Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil.

Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil.

Journal: Viruses

Published: June 15, 2023

Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine.

Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine.

Journal: Journal of viral hepatitis

Published: December 19, 2022

CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy.

CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy.

Journal: Journal of medical virology

Published: September 13, 2022

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.

Journal: Viruses

Published: July 29, 2022

Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug.

Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 08, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026